MLTX
Income statement / Annual
Last year (2024), MoonLake Immunotherapeutics's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, MoonLake Immunotherapeutics's net income was -$120.68 M.
See MoonLake Immunotherapeutics,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$13.16 K
|
$12.36 K
|
$4.97 K
|
$0.00
|
Gross Profit |
$0.00
|
-$13.16 K
|
-$12.36 K
|
-$4.97 K
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$111.39 M
|
$31.79 M
|
$42.05 M
|
$35.52 M
|
$0.00
|
General & Administrative Expenses |
$30.32 B
|
$22.32 M
|
$23.01 M
|
$21.66 M
|
$0.00
|
Selling & Marketing Expenses |
-$30.29 B
|
$0.00
|
$0.00
|
$18.03 M
|
$0.00
|
Selling, General & Administrative Expenses |
$30.32 M
|
$22.32 M
|
$23.01 M
|
$18.05 M
|
$105.76 K
|
Other Expenses |
$0.00
|
$0.00
|
$591.73 K
|
$0.00
|
$0.00
|
Operating Expenses |
$141.71 M
|
$54.12 M
|
$65.06 M
|
$53.57 M
|
$105.76 K
|
Cost And Expenses |
$0.00
|
$54.12 M
|
$65.06 M
|
$53.58 M
|
$105.76 K
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14.92 K
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$0.00
|
$13.16 K
|
$12.36 K
|
$4.97 K
|
$206.30 K
|
EBITDA |
-$119.58 M |
-$54.11 M |
-$65.05 M |
-$53.63 M |
-$90.84 K |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$0.00
|
$10.14 M
|
$591.73 K
|
$10.65 M
|
$14.92 K
|
Income Before Tax |
-$120.96 M
|
-$43.98 M
|
-$64.47 M
|
-$53.64 M
|
-$90.84 K
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$282.20 K
|
$94.39 K
|
$36.37 K
|
$4.76 K
|
-$206.30 K
|
Net Income |
-$120.68 M
|
-$36.01 M
|
-$64.51 M
|
-$53.64 M
|
-$90.84 K
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
EPS |
-1919.51 |
-0.73 |
-2.2 |
-6.84 |
-0.0061 |
EPS Diluted |
-1919.51 |
-0.73 |
-2.2 |
-6.84 |
-0.0061 |
Weighted Average Shares Out |
$62.87 M
|
$49.12 M
|
$29.36 M
|
$7.84 M
|
$14.81 M
|
Weighted Average Shares Out Diluted |
$62.87 M
|
$49.12 M
|
$29.36 M
|
$7.84 M
|
$14.81 M
|
Link |
|
|
|
|
|